Get the Stockscreener App
0.8517
7.25%
-0.0666
After Hours:
.80
-0.0517
-6.07%
Arcadia Biosciences Inc stock is traded at $0.8517, with a volume of 280.65K.
It is down -7.25% in the last 24 hours and down -10.87% over the past month.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
See More
Previous Close:
$0.9183
Open:
$0.869
24h Volume:
280.65K
Relative Volume:
0.10
Market Cap:
$1.75M
Revenue:
$4.76M
Net Income/Loss:
$-9.32M
P/E Ratio:
-0.1489
EPS:
-5.7182
Net Cash Flow:
$-4.25M
1W Performance:
-7.42%
1M Performance:
-10.87%
6M Performance:
-76.60%
1Y Performance:
-82.90%
1-Day Range:
$0.7651
$0.8868
1-Week Range:
$0.7651
$1.94
52-Week Range:
$0.7651
$6.71
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Name
Arcadia Biosciences Inc
Sector
Industry
Phone
214-974-8921
Address
5956 SHERRY LANE, DALLAS, CA
Compare RKDA vs JBS, KHC, GIS, HRL, MKC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
0.8517 | 1.89M | 4.76M | -9.32M | -4.25M | -5.7182 |
JBS
Jbs Nv
|
12.30 | 40.09B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
23.80 | 28.45B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
34.40 | 18.29B | 18.37B | 2.22B | 1.65B | 4.0676 |
HRL
Hormel Foods Corp
|
24.65 | 13.53B | 12.22B | 466.64M | 692.94M | 0.8477 |
MKC
Mccormick Co Inc
|
47.19 | 12.87B | 7.11B | 1.65B | 680.40M | 6.1005 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-20 | Reiterated | H.C. Wainwright | Buy |
| May-12-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-09-15 | Initiated | Credit Suisse | Outperform |
| Jun-09-15 | Initiated | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Stock (RKDA) Latest News
Arcadia Biosciences Announces $4 Million Private Placement - TipRanks
Arcadia Biosciences Raises ~$4 Million in Private Placement of Pre-Funded Warrants and Options - TradingView
Arcadia Biosciences (RKDA) completes $4M private placement with warrants and options - Stock Titan
RKDA Q3 2025 Earnings: Surprise Profit Beats Estimates by Wide MarginDownward Estimate Revision - newsline.com
Arcadia Biosciences closes $4 million private placement - Investing.com
Arcadia Biosciences closes $4 million private placement By Investing.com - Investing.com South Africa
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times
Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options - Quiver Quantitative
Arcadia Biosciences raises $4M in at-the-market stock deal - Stock Titan
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced ... - Caledonian Record
Arcadia Biosciences (RKDA) Announces Closing of $4 Million - GlobeNewswire
MSN Money - MSN
RKDA News | ARCADIA BIOSCIENCES INC (NASDAQ:RKDA) - ChartMill
Arcadia Biosciences Raises $4 Million in Private Placement - marketscreener.com
What Does Arcadia Biosciences' Latest $4 Million Private Placement Entail - Kavout
Wellness products maker Arcadia Biosciences lines up $4M in funding - Stock Titan
Arcadia Biosciences (RKDA) Secures Funding with New Share Agreem - GuruFocus
Arcadia Biosciences, Inc. Announces Private Placement of Common Stock and Preferred Investment Options to Raise Approximately $4 Million - Quiver Quantitative
Arcadia Biosciences raises $4 million in private placement - Investing.com
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under ... - Caledonian Record
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire Inc.
Arcadia Biosciences, Inc. announced that it has received $3.999613 million in funding - marketscreener.com
Arcadia Biosciences (RKDA) jumps 44.5% amid heavy volume, with no clear new headline catalyst - Quiver Quantitative
RKDA Stock Whipsaws As Traders Focus On Cash, Chart - StocksToTrade
RKDA Stock Slides As Volatile Chart Tests Day Traders - timothysykes.com
RKDA Q3 2025 Earnings: EPS Surge Beats Estimates Amid No Revenue DisclosureEarnings Volatility Report - newsline.com
Arcadia Biosciences (RKDA) Slips 1.89% as Stock Tests Key Support Near $0.86Golden Cross - newsline.com
RKDA Q3 2025 Earnings: Positive EPS Surprise Amidst Revenue ChallengesCore Business Growth - newsline.com
RKDA Stock Price, Quote & Chart - ChartMill
RKDA Q3 2025 Earnings: Surprise Profitability Without Reported RevenueEarnings Revision Upgrade - newsline.com
Arcadia Biosciences (RKDA) Slides to $0.95: Support Test on the HorizonIV Percentile - newsline.com
Arcadia Biosciences Stock Under $1: Why RKDA’s Next Move Hinges on Zola and Cash - Bez Kabli
Arcadia Biosciences (RKDA) Shows Modest Uptick Amid Consolidation Near Key LevelsChange of Character - newsline.com
Arcadia Biosciences (RKDA) Q3 2025 Profit Surges Past Wall Street TargetsFinancial Health Score - The Legal Advocate
RKDA Q3 2025 Earnings: Stunning EPS Surprise Driven by Non-Recurring Items, Stock RalliesProduct Revenue Analysis - newsline.com
RKDA Q3 2025 Earnings: Arcadia Biosciences Posts Surprise Profit as EPS Smashes EstimatesRising Community Picks - Newser
RKDA Stock Pops On Volume As Traders Hunt Volatility - StocksToTrade
RKDA Stock Slides As Traders Weigh Cash Runway And Charts - timothysykes.com
Arcadia Biosciences (RKDA) Rallies +27.91% as Bulls Target $1.29 2026-05-20Technical Analysis - newsline.com
Arcadia Biosciences (RKDA) Q3 2025 Beat: Revenue $N/A, EPS Exceeds by SignificantDividend Growth Analysis - The Legal Advocate
Armistice Capital (RKDA) reports 159,390 shares, 7.75% stake - Stock Titan
Arcadia Biosciences (RKDA) Delivers Q3 2025 Beat — EPS $0.62 vs $-0.55 ExpectedRevenue Guidance - newser.com
Arcadia Biosciences: Q1 Earnings Snapshot - KTVB
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights - The Manila Times
RKDA: Zola volumes rose 18% but net loss widened to $4.4M on lower revenue and one-time charges - TradingView
Arcadia Biosciences | 10-Q: Q1 2026 Earnings Report - Moomoo
Arcadia Biosciences (RKDA) Q1 2026 loss deepens amid going concern risk - Stock Titan
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[8-K] Arcadia Biosciences, Inc. Reports Material Event - Stock Titan
Arcadia Biosciences stock (US03020Q1058): Recent price volatility draws attention - AD HOC NEWS
TradingKey - TradingKey
Arcadia Biosciences Inc Stock (RKDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
1.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):